JENNIFER CASOLA: Open Payments
NPI 1992366967 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 92 payments from 16 companies in 2025. Trend: 2023 $2,184 · 2024 $1,960 · 2025 $2,190
Food & beverage: $2,190
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $447 |
| AstraZeneca Pharmaceuticals LP | 5 | $371 |
| ABBVIE INC. | 7 | $240 |
| GlaxoSmithKline, LLC. | 12 | $223 |
| PFIZER INC. | 15 | $197 |
| Novo Nordisk Inc | 10 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Astellas Pharma US Inc | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| HARMONY BIOSCIENCES LLC | 2 | $60 |
Products named: REPATHA, TRELEGY ELLIPTA, Wegovy, OTEZLA, FARXIGA, NURTEC ODT, CREON, BREZTRI.
Industry payments across FL — which companies pay providers there.
